OSR HEALTH, INC. Increase (Decrease) in Prepaid Expense
OSR HEALTH, INC. (OSRH) reported Increase (Decrease) in Prepaid Expense of $20.16 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2024-11-14
- OSR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2024-09-30 was -$20.34K.
- OSR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2024-06-30 was -$16.83K.
- OSR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2024-03-31 was $57.34K, a 29.28% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in prepaid expense for the quarter ending 2023-12-31 was -$17.25K.
- OSR HEALTH, INC. increase (decrease) in prepaid expense for fiscal 2023 was $7.21K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$20.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$37.17K derived: sum of 2 quarters · filed 2024-11-14 | $20.16K 10-Q · filed 2024-11-14 | $2.91K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | -$16.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $40.50K 10-Q · filed 2024-08-19 | $23.25K derived: sum of 3 quarters · filed 2024-08-19 | -$10.08K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $57.34K 10-Q · filed 2024-05-15 | $40.08K derived: sum of 2 quarters · filed 2024-05-15 | $6.75K derived: sum of 3 quarters · filed 2024-11-14 | -$16.53K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | -$17.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | -$50.59K derived: sum of 2 quarters · filed 2024-11-14 | -$73.86K derived: sum of 3 quarters · filed 2024-11-14 | $7.21K 10-K · filed 2024-04-17 |
| 2023-09-30 | -$33.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$56.61K derived: sum of 2 quarters · filed 2024-11-14 | $24.46K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$23.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $57.80K 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | $81.07K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |